Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01-10753-1 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inclusion Criteria:
opiate experienced, healthy
Exclusion Criteria:
physical dependence on opioids, barbiturates or alcohol
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sharon Walsh, Ph.D. | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins University (BPRU) Bayview Campus | Baltimore | Maryland | 21224 6823 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 11594439 | Background | Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl). 2001 Sep;157(2):151-62. doi: 10.1007/s002130100788. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019970 | Cocaine-Related Disorders |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided